文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

合并症与新发血脂异常对HIV抑制者ART换药概率的影响

Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

该回顾性巢式病例对照研究基于Icona Foundation Study队列,评估HIV RNA≤50 copies/mL者新发血脂异常、肾病和体重致超重的发生率及换药可能性。血脂异常是最常见新发合并症(138例,发生率28.4%,95%CI 22.7%-34%)。因毒性换药与新发血脂异常相关(aOR=2.49,95%CI 1.19-5.19,P=0.02),在基线使用含增效PI方案者中关联更强(aOR=3.38,95%CI 1.11-10.30,P=0.03)。

要点

  • 血脂异常是病毒稳定抑制的HIV感染者最常见新发合并症,发生率28.4%。
  • 新发血脂异常与因毒性换药风险升高相关(aOR=2.49,95%CI 1.19-5.19,P=0.02)。
  • 基线使用含增效PI方案者中,血脂异常与因毒性换药的关联更强(aOR=3.38,95%CI 1.11-10.30,P=0.03)。

核心结论

  • 新发血脂异常和eGFR下降与因毒性导致的换药相关。
  • 旨在减少血脂异常风险的干预可能减少ART更换次数。

研究设计与样本

  • 在Icona Foundation Study队列中嵌套六项病例对照研究,研究对象为病毒载量稳定≤50 copies/mL的HIV感染者。
  • 采用条件logistic回归模型分析。

主要发现

  • 研究参与者中位年龄45岁(IQR 36-52),女性占19%,MSM占48%,移民占17%。
  • 血脂异常是最常见新发合并症(138例事件,发生率28.4%,95%CI 22.7%-34%),其次为eGFR下降和BMI升高。
  • 因简化换药的风险与所研究因素均无关联。
  • 因毒性换药与新发血脂异常相关(aOR=2.49,95%CI 1.19-5.19,P=0.02),与eGFR下降>10 mL/min/1.73 m2相关(aOR=1.51,95%CI 0.98-2.32,P=0.06)。
  • 在基线使用含增效PI方案者中,血脂异常与因毒性换药的关联更强(aOR=3.38,95%CI 1.11-10.30,P=0.03)。

临床怎么用

  • 因毒性/简化而停药在病毒载量≤50 copies/mL的HIV感染者中近年仍常见。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To estimate the incidence of comorbidities in persons with HIV (PWH) with a stable viral load (VL) of ≤50 copies/mL and evaluate the likelihood of treatment switch (TS) according to the new development of dyslipidaemia (DP), kidney disease and a weight change that determined overweight. METHODS: We carried out six case-control studies nested within the Icona Foundation Study cohort with the outcome of TS of the current regimen (due to intolerance/toxicity or simplification) and investigated the incident comorbidities. Conditional logistic regression models were employed. RESULTS: Overall, the median age of study participants was 45 years (IQR: 36-52), 19% were female, 48% were MSM and 17% were migrants. DP was confirmed to be the most frequent incident comorbidity [138 events; incidence rate (IR) = 28.4%; 95% CI: 22.7%-34%], followed by estimated glomerular filtration rate (eGFR) deterioration and BMI elevation. None of the studied factors was associated with the risk of TS because of simplification. TS because of toxicity was predicted by incident DP [adjusted OR (aOR) = 2.49, 95% CI: 1.19-5.19, P = 0.02] and by a decline in eGFR of >10 mL/min/1.73 m2 (aOR = 1.51, 95% CI: 0.98-2.32, P = 0.06). The association with DP was stronger in participants who were receiving a boosted PI-based regimen at baseline (aOR = 3.38, 95% CI: 1.11-10.30, P = 0.03). Therapy discontinuation because of toxicity/simplification has remained common in PWH with VL of ≤50 copies/mL in recent years. CONCLUSIONS: The onset of DP and a decline in eGFR was associated with discontinuations due to toxicity. Interventions aiming to mitigate the risk of developing lipid abnormalities in PWH are likely to also reduce the number of ART changes, which can potentially affect future drug options.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Cozzi-Lepri A, Tavelli A, Taramasso L, et al. Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy. J Antimicrob Chemother. 2025. PMID: 40354062. doi:10.1093/jac/dkaf137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。